← Back

EP. 4: Advancements, Unmet Needs, and Future Trends in the Treatment of NMIBC

February 21, 2025

Dr Mark Tyson discusses how significant unmet needs in NMIBC treatment persist around BCG supply shortages, optimal treatment sequencing, biomarker development for patient selection, and reducing treatment toxicity, while expressing optimism about emerging trends in combination therapies, novel delivery systems, and personalized medicine approaches based on molecular profiling.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Additional Resources

      EP. 1: Treatment Strategies for Patients with NMIBC: Importance of Risk Stratification

      EP. 1: Treatment Strategies for Patients with NMIBC: Importance of Risk Stratification

      EP. 2: Transurethral Resection and Cystectomy in Patients with NMIBC

      EP. 2: Transurethral Resection and Cystectomy in Patients with NMIBC

      EP. 3: Emerging Treatments for Patients with NMIBC

      EP. 3: Emerging Treatments for Patients with NMIBC

      EP. 4: Advancements, Unmet Needs, and Future Trends in the Treatment of NMIBC

      EP. 4: Advancements, Unmet Needs, and Future Trends in the Treatment of NMIBC

      © 2025 MJH Life Sciences

      All rights reserved.